HydroMARK Direct Puncture 15G Breast Biopsy Marker Overview
Authorized Mammotome breast biopsy marker supplier. The HydroMARK Direct Puncture marker (PN 4010-02-15-T4) uses a titanium core and an exclusive hydrogel carrier. As a result, it delivers long-term ultrasound visibility at the biopsy site. This 15G marker deploys in a T4 shape. Therefore clinicians gain a clear and durable target for later imaging.
The marker stays visible under ultrasound for up to 12 months, even after neoadjuvant chemotherapy. In addition, it produces a unique anechoic appearance under ultrasound and reads clearly on an MRI T2 sequence. Because Mammotome indicates it for axillary lymph nodes and breast tissue, it fits a wide range of breast care pathways. For example, it supports ultrasound, stereotactic, and MR-guided marking.
Need pricing? Get a quote with lead times within one business day.
Features of the HydroMARK Direct Puncture Marker
This marker focuses on durable visibility across imaging modalities. In addition, it uses a simple direct puncture applicator for straightforward placement.
Mammotome builds this marker from titanium with an exclusive hydrogel carrier. Because of that hydrogel, the marker gives long-term ultrasound visibility at the biopsy site.
Clinicians can see the marker under ultrasound for up to 12 months. In addition, it holds that visibility even after neoadjuvant chemotherapy. The marker also shows a unique anechoic appearance, so it stands out during ultrasound-guided review.
The marker reads clearly on an MRI T2 sequence. Therefore it supports follow-up across ultrasound and magnetic resonance imaging.
Mammotome indicates the marker for axillary lymph nodes and breast tissue. As a result, it works within ultrasound, stereotactic, and MR-guided marking pathways. The 15G T4 configuration deploys through a direct puncture applicator for a simple workflow.
Here is how a generic metal clip marker compares with the HydroMARK Direct Puncture marker.
Choosing the right marker matters at every stage of care. Therefore this marker pairs long-term ultrasound visibility with reliable MRI detection, which helps teams locate the biopsy site later.
Full Specifications
The specifications below reflect only the details published by Mammotome for this marker. Please confirm regional availability with your local Mammotome representative.
| Product | Mammotome HydroMARK Direct Puncture Marker |
| Part number | 4010-02-15-T4 |
| Marker shape | T4 |
| Needle gauge | 15G |
| Brand | Mammotome |
| Manufacturer | Devicor Medical Products, Inc. |
| Marker core | Titanium |
| Carrier | Hydrogel |
| Portfolio | HydroMARK |
| Delivery method | Direct puncture applicator |
| Ultrasound visibility | Up to 12 months |
| Ultrasound appearance | Anechoic |
| MRI visibility | T2 sequence |
| After neoadjuvant chemotherapy | Up to 12 months |
| Indicated for | Axillary lymph nodes and breast tissue |
| Ultrasound-guided marking | Supported |
| Stereotactic marking | Supported |
| MR-guided marking | Supported |
| Hologic | ATEC, Eviva, Brevera, Celero |
| Bard | EnCor Enspire |
| BD | EleVation |
| Core needle | Traditional spring-loaded devices |
Clinical Applications
This marker supports several breast care scenarios. Each one benefits from durable ultrasound visibility and reliable multimodality detection.
Surgeons often plan excision weeks or months after biopsy. Because the marker stays visible for up to 12 months, it provides a steady target for that planning.
Some patients receive neoadjuvant chemotherapy before surgery. In addition, this marker keeps its ultrasound visibility even after that treatment, which helps teams find the original site.
Clinicians frequently rely on ultrasound at the point of care. Therefore the unique anechoic appearance makes the marker easy to identify during ultrasound review.
MRI plays a growing role in breast imaging. As a result, this marker reads clearly on an MRI T2 sequence for confident follow-up.
Mammotome indicates the marker for axillary lymph nodes. Because of that, care teams can mark suspicious nodes for later assessment.
Many programs use ultrasound, stereotactic, and MR guidance together. This marker supports all three pathways, so it fits varied clinical needs.
HydroMARK Direct Puncture Biopsy Marking Workflow
The direct puncture applicator keeps marker placement simple. Here is how the marker fits into a typical breast biopsy pathway.
The clinician performs the breast biopsy first. Then the team prepares to mark the biopsy cavity for future reference.
The clinician places the 15G T4 marker using the direct puncture applicator. Because the applicator is simple, deployment stays straightforward.
The titanium and hydrogel marker appears anechoic under ultrasound. As a result, the team can confirm placement at the time of the procedure.
The hydrogel carrier keeps the marker visible for up to 12 months. Therefore it remains a reliable target through surgical planning, even after chemotherapy.
The marker reads clearly on an MRI T2 sequence. In addition, it supports stereotactic and MR-guided assessment across the care journey.
Compliance and Product Information
Please review the manufacturer documentation and confirm regional availability before ordering.
The product and its indications may not be approved or available in every region. Therefore please check with your local Mammotome representative before ordering.
For complete product details, always refer to the manufacturer Instructions for Use. In addition, follow your facility protocols for marker placement and imaging.
Devicor, Mammotome, and HydroMARK are registered trademarks of Devicor Medical Products, Inc. The marker is manufactured by Devicor Medical Products, Inc.
Medical Outfitters Inc. operates a quality management system certified to ISO 13485:2016. As a result, we supply this Mammotome marker with documented sourcing and handling practices from our Miami, Florida facility.
Request a Quote
Contact Medical Outfitters Inc. for current pricing and lead time on the Mammotome HydroMARK Direct Puncture 15G T4 marker. In addition, we can help match markers to your biopsy devices.
Talk to a Specialist
Our team can review compatibility with your ultrasound, stereotactic, and MR-guided systems. Call (305) 885-4045 to speak with a product specialist.
Frequently Asked Questions
Below are common questions about the Mammotome HydroMARK Direct Puncture 15G T4 marker.
It is a titanium breast biopsy site marker with an exclusive hydrogel carrier. It deploys in a T4 shape through a 15G direct puncture applicator. As a result, it marks the biopsy site for future imaging.
The marker stays visible under ultrasound for up to 12 months. In addition, it retains that visibility even after neoadjuvant chemotherapy.
Yes. The marker reads clearly on an MRI T2 sequence. Therefore it supports follow-up imaging with magnetic resonance.
It is made of titanium with a hydrogel carrier. Because of the hydrogel, it delivers long-term ultrasound visibility and a unique anechoic appearance.
The part number identifies a 15G HydroMARK marker in the T4 shape. It ships with a direct puncture applicator for placement.
Mammotome lists compatibility with several non-Mammotome devices. For example, these include Hologic ATEC, Eviva, Brevera, and Celero, along with Bard EnCor Enspire and BD EleVation devices.
The product and its indications may not be approved or available in every region. Therefore please confirm current status with your local Mammotome representative.
You can buy it from Medical Outfitters Inc., an ISO 13485:2016 certified supplier in Miami, FL. Call (305) 885-4045 for pricing and availability.
Compatible Equipment
Explore related breast biopsy markers and devices available from Medical Outfitters Inc.



Request a Quote Today
Get in touch with Medical Outfitters today to request your personalized quote and outfit your facility with confidence.